Folic Acid
Best for
Lower neural tube defect risk
Proven strong benefit · 0.36–4 mg/day for 12–16 weeks · 1 meta-analysis , n=7k
46 papers · 6 claims · 72 outcomes scored · 4 positive
Outcomes
What folic acid actually does, by outcome
Each row is one outcome with effect size, evidence base, the dose that worked in trials, and time to first effect. Magnitude tiers come from native-unit MCID where available, Cohen's d otherwise.
Fuels the rapid cell division that seals the spine before week four.
Clears a vessel-irritating byproduct that builds when nutrient recycling falls behind.
Tops up the reserves pregnancy drains fastest.
Brings down both systolic and diastolic, especially when baseline runs high.
May help support normal heart formation in early pregnancy.
Reduces the chance of early delivery, especially before 34 weeks.
| Outcome | Effect | Evidence | Dose | Weeks | Rank |
|---|---|---|---|---|---|
| Lower neural tube defect risk Proven strong benefit | | 4 meta-analyses n=7.0k Meta-analyzed | 0.36–4 mg | 12–16 wk | — |
| Lower homocysteine levels Proven strong benefit | | 19 meta-analyses n=3.2k Meta-analyzed | 0.25–2000 mg | 4–52 wk | #1/12 |
| Build nutrient stores in pregnancy Proven benefit | | 17 meta-analyses n=1.4k Meta-analyzed | 0–1429 mcg | 4–52 wk | #1/4 |
| Lower your blood pressure Likely real but unnoticeable | | 3 RCTs n=367 | 0.4–5 mg | 6–24 wk | #10/81 |
| Lower congenital heart defect risk Not enough research | | 1 meta-analysis n=107k Meta-analyzed | — | — | — |
| Lower preterm birth risk Not enough research | | 1 RCT n=2.3k | 4 mg | — | — |
Recommended Folic Acid products
Real products that dose Folic Acid where the research does, in a clean formulation, from brands we've audited. We only list ones we'd stand behind.
-
Seeking Health
HomocysteX Plus with TMG
Well dosed 1,360 mcg DFE/day A formulaBrand audit 85/100
-
Life Extension
Prenatal Advantage
Well dosed 4,080 mcg DFE/day B formulaBrand audit 90/100
-
KAL
Methyl Folate 800 mcg
Well dosed 800 mcg/day B formula -
Solaray
Methyl B-Complex 50
Well dosed 400 mcg/day C formulaBrand audit 76/100
-
Innate Response Formulas
One Daily Cap
Well dosed 400 mcg/day A formula -
Innate Response Formulas
Complete Multi Powder
Well dosed 400 mcg/day A formula
Chosen for adequate Folic Acid dosing vs. the studied range, a clean formulation (grade A–C), and independent brand-quality audits. Not sponsored.
Risk profile
Adverse events and known drug interactions
Safety events
Sources
- 1. A randomised trial of low dose folic acid to prevent neural tube defects. The Irish Vitamin Study Group. (1992) ↑
- 2. Effects and safety of periconceptional oral folate supplementation for preventing birth defects. (2015) ↑
- 3. Weekly iron-folic acid supplements containing 2.8 mg folic acid are associated with a lower risk of neural tube defects than the current practice of 0.4 mg: a randomised controlled trial in Malaysia. (2020) ↑
- 4. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. (1981) ↑
- 5. Effect of folic acid and betaine supplementation on flow-mediated dilation: a randomized, controlled study in healthy volunteers. (2006) ↑
- 6. Effect of physiological doses of oral vitamin B12 on plasma homocysteine: a randomized, placebo-controlled, double-blind trial in India. (2010) ↑
- 7. Effects of folic acid supplementation on serum folate and plasma homocysteine concentrations in older adults: a dose-response trial. (2010) ↑
- 8. MTHFR C677T and MTR A2756G polymorphisms and the homocysteine lowering efficacy of different doses of folic acid in hypertensive Chinese adults. (2012) ↑
- 9. Homocysteine lowering by folate-rich diet or pharmacological supplementations in subjects with moderate hyperhomocysteinemia. (2013) ↑
- 10. Effect of folic acid on bone metabolism: a randomized double blind clinical trial in postmenopausal osteoporotic women. (2014) ↑
Generated August 14, 2026